Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Ribon Therapeutics
99 Hayden Avenue, Building D, Suite 100
Lexington, MA 02421
Phone: 617-914-8700
http://www.ribontx.com/

Ribon Therapeutics is a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions that contribute to disease. We are exploring novel areas of biology to develop effective treatments for patients with limited therapeutic options. Leveraging a chemical biology approach and our proprietary discovery platform, we are building a pipeline of selective, small molecule inhibitors to numerous NAD+ utilizing enzymes, beginning with monoPARPs, which have applications across multiple therapeutic areas. Our lead program is developing PARP7 inhibitors for the treatment of cancer.

Key Contact
NameTitleE-Mail
Victoria RichonCEOvrichon@ribontx.com


Funding Events
DateAmountTypeInvestors
01/04/19$65,000,000Series B Celgene Corporation
Deerfield Management Company, L.P.
Euclidean Capital
Johnson & Johnson Development Corporation (JJDC)
Novartis Venture Funds  
Osage University Partners
Takeda Ventures
The Column Group
US Venture Partners
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.